Viewing Study NCT06291103


Ignite Creation Date: 2025-12-24 @ 7:35 PM
Ignite Modification Date: 2025-12-28 @ 12:07 PM
Study NCT ID: NCT06291103
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-03-04
First Post: 2024-02-26
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Screening for Subclinical Antibody Mediated Rejection and Efficacy of Belatacept in the Context of de Novo Donor Specific Antibody After Kidney Transplantation (BELA-M-R)
Sponsor: University Hospital, Rouen
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module